Your browser doesn't support javascript.
loading
Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer.
Brunsvig, Paal F; Guren, Tormod Kyrre; Nyakas, Marta; Steinfeldt-Reisse, Claudius H; Rasch, Wenche; Kyte, Jon Amund; Juul, Hedvig Vidarsdotter; Aamdal, Steinar; Gaudernack, Gustav; Inderberg, Else Marit.
Afiliación
  • Brunsvig PF; Department of Clinical Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
  • Guren TK; Department of Clinical Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
  • Nyakas M; Department of Clinical Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
  • Steinfeldt-Reisse CH; Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Rasch W; Ultimovacs ASA, Oslo, Norway.
  • Kyte JA; Department of Clinical Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
  • Juul HV; Department of Cellular Therapy, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
  • Aamdal S; Ultimovacs ASA, Oslo, Norway.
  • Gaudernack G; Ultimovacs ASA, Oslo, Norway.
  • Inderberg EM; Department of Cellular Therapy, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
Front Immunol ; 11: 572172, 2020.
Article en En | MEDLINE | ID: mdl-33324397

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Carcinoma de Pulmón de Células no Pequeñas / Telomerasa / Epítopos de Linfocito T / Vacunas contra el Cáncer / Inmunoterapia / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Carcinoma de Pulmón de Células no Pequeñas / Telomerasa / Epítopos de Linfocito T / Vacunas contra el Cáncer / Inmunoterapia / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Suiza